Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Literature Review

Posted on By

SOP for Pharmacovigilance Literature Review

Guidelines for Conducting Pharmacovigilance Literature Review

1) Purpose

The purpose of this SOP is to establish standardized procedures for conducting literature reviews to identify and evaluate safety information on medicinal products.

2) Scope

This SOP applies to all pharmacovigilance personnel involved in the literature review process, including safety specialists, medical writers, and managers.

3) Responsibilities

The Literature Review Team is responsible for performing comprehensive literature reviews and extracting relevant safety information. The Pharmacovigilance (PV) Manager oversees the process to ensure compliance with regulatory requirements and internal standards.

4) Procedure

4.1 Preparation for Literature Review

  1. Identify the scope and objectives of the literature review.
  2. Define the search criteria, including keywords, databases, and timeframes.
  3. Document the search strategy in a literature review plan.
See also  SOP for Pharmacovigilance Post-Authorization Safety Studies (PASS)

4.2 Conducting the Literature Search

  1. Perform literature searches using relevant databases (e.g., PubMed, Embase, Google Scholar).
  2. Use predefined keywords and filters to retrieve relevant articles.
  3. Save and document the search results, including the search date, databases used, and total number of articles retrieved.

4.3 Screening and Selection of Articles

  1. Review the titles and abstracts of the retrieved articles to determine their relevance to pharmacovigilance.
  2. Include articles that contain safety information on the medicinal products of interest.
  3. Exclude articles that do not meet the relevance criteria, documenting the reasons for exclusion.

4.4 Detailed Review and Data

Extraction

  1. Perform a detailed review of the full text of the selected relevant articles.
  2. Extract relevant safety information, including adverse events, risk factors, and benefit-risk assessments.
  3. Summarize the findings and document them in a literature review report.
See also  SOP for Pharmacovigilance Risk Communication Plan

4.5 Evaluation and Interpretation

  1. Evaluate the extracted data to determine its impact on the safety profile of the medicinal product.
  2. Interpret the findings in the context of existing safety information and regulatory requirements.
  3. Document the evaluation and interpretation in the literature review report.

4.6 Documentation and Record Keeping

  1. Maintain detailed records of all literature searches, including search strategies, results, and review notes.
  2. Ensure all documentation is securely stored and easily accessible for audits and inspections.

4.7 Quality Control

  1. Conduct regular quality control checks on the literature review process to ensure accuracy and consistency.
  2. Address any discrepancies or errors identified during quality control checks promptly.
  3. Document all quality control activities and any corrective actions taken.
See also  SOP for Pharmacovigilance Contract Management

4.8 Training and Communication

  1. Communicate literature review procedures and updates to all relevant staff members.
  2. Provide training on literature search tools and techniques to ensure consistency and quality.
  3. Report any issues or challenges encountered during the literature review process to the PV Manager.

5) Abbreviations, if any

PV – Pharmacovigilance

6) Documents, if any

Search strategies, search results, review notes, literature review reports.

7) Reference, if any

ICH E2E Pharmacovigilance Planning, EU Good Pharmacovigilance Practices (GVP) Module VI.

8) SOP Version

Version 1.0

Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

Post navigation

Previous Post: SOP for Analytical Method Development Method Optimization
Next Post: Aerosols: SOP for Root Cause Analysis in Aerosol Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version